Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
08/05/2025
Insiders said that CATL plans to price its shares in its $5 billion Hong Kong listing plan at a discount of less than 10% compared to its Shenzhen-listed shares.
Latest
6 m ago
Powell: The risks of higher unemployment and higher inflation rates have increased but have not yet been reflected in the data.
6 m ago
Powell: If both inflation and unemployment rates rise, the Federal Reserve will face a difficult decision.
7 m ago
The Central Bank of the United Arab Emirates will maintain the benchmark interest rate at 4.40%.
7 m ago
Federal Reserve Chairman Powell said that President Trump's call for a rate cut will not affect the work of the Federal Reserve at all.
7 m ago
Needham: Maintain a Buy rating on Rhythm Pharmaceuticals (RYTM.US), adjusting from Buy to Buy rating, with a target price adjusted from $66.00 to $72.00.
See all latest